StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Short-Term Financial Debt & Current Portion Due Within by Quarter

Short-Term Financial Debt & Current Portion Due Within 1 Year (current-debt) ($M)

QuarterlyAnnual

Novartis Short-Term Financial Debt & Current Portion Due Within: $9,650M in Q3 2026, up 28.3% from a year earlier.

Latest, Q3 2026
9,650
Period ended Sep 30, 2026
Change on a year earlier
+28.3%
7,520 in Q3 2025
History
32 quarters
Since Q4 2018
Sources
24
Documents cited below

Where the Q3 2026 figure comes from

“|| Financial debts and derivative financial instruments | 9 650 | 5 602”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShort-Term Financial Debt & Current Portion Due Within 1 Year (current-debt) ($M)Year on yearSource
Q3 2026Sep 30, 20269,650+28.3%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20269,588+15.3%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20267,617-2.4%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20255,602-31.9%Novartis Form 6-K (0001114448-26-000014) ↗
Q3 2025Sep 30, 20257,520+14.5%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 20258,314+10.4%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 20257,801-6.5%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 20248,232+33.3%Novartis Form 6-K (0001114448-25-000003) ↗
Q3 2024Sep 30, 20246,566+20.3%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 20247,532-9.1%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 20248,339+19.7%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 20236,175+4.1%Novartis Form 6-K (0001370368-24-000022) ↗
Q3 2023Sep 30, 20235,458-22.6%Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 20238,289+17.7%Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 20236,968+4.1%Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 20225,931-5.8%Novartis Form 6-K (0001370368-23-000068) ↗

Cite this data

StockData. (2026). Novartis Short-Term Financial Debt & Current Portion Due Within ($M), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-curr-debt

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.